Merck's HPV vaccine gets China approval for men

Merck's HPV vaccine gets China approval for men amid declining sales
Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among women.
China's first HPV vaccine for men approved for market
The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products Administration, becoming the first and only HPV vaccine authorized for use in men in China,
Gardasil Gains Ground: Merck's HPV Vaccine for Men Approved in China
Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help Merck overcome declining sales due to weak demand among women and disruptions caused by China's anti-corruption campaign.
Merck says HPV vaccine for men approved by China's drug regulator
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in a key market.
Merck Gets China Nod on HPV Shot for Men Amid Sales Slump
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the US drug giant after a rush among women to get the shot lost steam.
China administers its first dose of HPV vaccine for men
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV vaccine, after US pharmaceutical giant Merck announced its quadrivalent HPV vaccine Gardasil had been approved for additional indications by the National Medical Products Administration.
Merck’s Gardasil receives expanded approval for males in China
Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja
China’s drug regulator gives nod to HPV vaccine for men
U.S. drugmaker Merck & Co on Wednesday announced that its human papillomavirus (HPV) vaccine for men has been approved by China’s medical products administration. According to a report by news agency Reuters, this is a much-needed boost to the company in a key market.
Merck HPV vaccine for men approved in China
Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration for men aged 9-26 years.Gardasil, a key product for Merck alongside
Merck's HPV Vaccine Gains Ground in China
U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth opportunity as Gardasil has been key to Merck's market strategy alongside cancer treatment Keytruda.
Cervical Cancer Awareness Month: Know how the HPV vaccine helps reduce the risks of cervical cancer
People across the world are observing Cervical Awareness Month in January to raise awareness about the disease. Now, let us ...
The Manhattan Mercury7h
This cancer vaccine should spare future generations from ordeals like my wife’s
Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile became crooked.